Amphastar Pharmaceuticals (NASDAQ:AMPH) Cut to Hold at StockNews.com
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Friday. Several other equities analysts also recently commented on AMPH. Jefferies Financial Group assumed coverage on shares of Amphastar Pharmaceuticals in a report on Tuesday, July 25th. … Read more